Eli Lilly Balance Sheet Health
Financial Health criteria checks 3/6
Eli Lilly has a total shareholder equity of $13.6B and total debt of $29.0B, which brings its debt-to-equity ratio to 212.9%. Its total assets and total liabilities are $71.9B and $58.2B respectively. Eli Lilly's EBIT is $13.9B making its interest coverage ratio 30.9. It has cash and short-term investments of $3.4B.
Key information
212.9%
Debt to equity ratio
US$29.03b
Debt
| Interest coverage ratio | 30.9x |
| Cash | US$3.37b |
| Equity | US$13.64b |
| Total liabilities | US$58.24b |
| Total assets | US$71.87b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LLYD's short term assets ($30.2B) exceed its short term liabilities ($27.1B).
Long Term Liabilities: LLYD's short term assets ($30.2B) do not cover its long term liabilities ($31.1B).
Debt to Equity History and Analysis
Debt Level: LLYD's net debt to equity ratio (188.2%) is considered high.
Reducing Debt: LLYD's debt to equity ratio has reduced from 553.4% to 212.9% over the past 5 years.
Debt Coverage: LLYD's debt is not well covered by operating cash flow (15.5%).
Interest Coverage: LLYD's interest payments on its debt are well covered by EBIT (30.9x coverage).